143 related articles for article (PubMed ID: 37052239)
21. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
Du M; Wang X; Yuan L; Liu B; Mao X; Huang D; Yang L; Huang K; Zhang F; Wang Y; Luo X; Wang C; Peng J; Liang M; Huang D; Huang K
J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288
[TBL] [Abstract][Full Text] [Related]
22. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
23. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
25. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
[TBL] [Abstract][Full Text] [Related]
26. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway.
Liu Y; Xu W; Zhai T; You J; Chen Y
Acta Pharm Sin B; 2019 Jul; 9(4):745-757. PubMed ID: 31384535
[TBL] [Abstract][Full Text] [Related]
27. PPAR
Yang W; Yuan W; Peng X; Wang M; Xiao J; Wu C; Luo L
Mediators Inflamm; 2019; 2019():5618023. PubMed ID: 31871428
[TBL] [Abstract][Full Text] [Related]
28. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
29. Black ginseng protects against Western diet-induced nonalcoholic steatohepatitis by modulating the TLR4/NF-κB signaling pathway in mice.
Wei W; Liu L; Liu X; Tao Y; Gong J; Wang Y; Liu S
J Food Biochem; 2022 Dec; 46(12):e14432. PubMed ID: 36183169
[TBL] [Abstract][Full Text] [Related]
30. (Pro)renin receptor inhibition attenuated liver steatosis, inflammation, and fibrosis in mice with steatohepatitis.
Hsieh YC; Wu PS; Lin YT; Huang YH; Hou MC; Lee KC; Lin HC
FASEB J; 2022 Oct; 36(10):e22526. PubMed ID: 36063123
[TBL] [Abstract][Full Text] [Related]
31. Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-β1 signaling-mediated hepatocyte apoptosis.
Liu D; Wang K; Li K; Xu R; Chang X; Zhu Y; Sun P; Han X
Cell Death Dis; 2019 Jun; 10(6):458. PubMed ID: 31189885
[TBL] [Abstract][Full Text] [Related]
32. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
Zhao X; Xue J; Wang XL; Zhang Y; Deng M; Xie ML
Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341
[TBL] [Abstract][Full Text] [Related]
33. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway.
Ma Z; Chu L; Liu H; Li J; Zhang Y; Liu W; Dai J; Yi J; Gao Y
Int Immunopharmacol; 2016 Sep; 38():377-84. PubMed ID: 27351828
[TBL] [Abstract][Full Text] [Related]
34. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
[TBL] [Abstract][Full Text] [Related]
35. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice.
Luo Y; Dong X; Yu Y; Sun G; Sun X
J Ethnopharmacol; 2015 Apr; 163():241-50. PubMed ID: 25655997
[TBL] [Abstract][Full Text] [Related]
36. High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis.
Chen X; Acquaah-Mensah GK; Denning KL; Peterson JM; Wang K; Denvir J; Hong F; Cederbaum AI; Lu Y
Am J Physiol Gastrointest Liver Physiol; 2020 Nov; 319(5):G626-G635. PubMed ID: 32877213
[TBL] [Abstract][Full Text] [Related]
37. Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice.
Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
Int Immunopharmacol; 2019 Oct; 75():105797. PubMed ID: 31421545
[TBL] [Abstract][Full Text] [Related]
38. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y
Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916
[TBL] [Abstract][Full Text] [Related]
39. Diethyldithiocarbamate inhibits the activation of hepatic stellate cells via PPARα/FABP1 in mice with non-alcoholic steatohepatitis.
Sun X; Yu Q; Kang B; Zhao X; Li H; Liu H; Liu L; Wang P; Cong M; Liu T
Biochem Biophys Res Commun; 2023 Jan; 641():192-199. PubMed ID: 36535078
[TBL] [Abstract][Full Text] [Related]
40. Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
Ratziu V; Harrison SA; Francque S; Bedossa P; Lehert P; Serfaty L; Romero-Gomez M; Boursier J; Abdelmalek M; Caldwell S; Drenth J; Anstee QM; Hum D; Hanf R; Roudot A; Megnien S; Staels B; Sanyal A;
Gastroenterology; 2016 May; 150(5):1147-1159.e5. PubMed ID: 26874076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]